PSKOF yields 4.61% · PFE yields 6.13%● Live data
📍 PSKOF pulled ahead of the other in Year 1
Combined, PSKOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PSKOF + PFE for your $10,000?
Polski Koncern Naftowy ORLEN Spólka Akcyjna, together with its subsidiaries, engages in the extraction, processing, refining, storage, and wholesale of crude oil in Poland, Germany, the Czech Republic, Lithuania, Malta, Sweden, Slovakia, Hungary, Estonia, Latvia, Canada, and China. It operates through Refining, Petrochemical, Energy, Retail, and Upstream segments. The company offers petrol, diesel, LPG, and biofuels; aviation fuels; heating oils; aromatics, including phenol, benzene, paraxylene, purified terephthalic acid, benzene-toulene fraction, and naphthalene concentrate; olefins; polyolefins; plastics; glycols; nitrogen fertilizers; and other products, such as acetone, ethylene oxide, masterbatch, advanced technical carbon black Chezacarb, caprolactam, soda lye, and sodium hypochlorite. It also provides base, car and motorbike, truck, marine, industrial, and agricultural oils; and paraffin and solvents. In addition, the company produces, distributes, and transmits electricity and heat energy with an installed power capacity of approximately 3.4 GW; and trades in thermal energy. As of December 31, 2021, it had a network of 2,881 fuel stations. The company was founded in 1999 and is headquartered in Plock, Poland.
Full PSKOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.